Cataract Surgery Devices Market to Reach US$ 8.2 Billion by 2031, Growing at a CAGR of 7.0% Driven by Premium IOLs, Phacoemulsification Systems, and FLACS | DataM Intelligence

The global cataract surgery devices market reached US$4.8 billion in 2023, rising to US$5.1 billion in 2024 and is expected to reach US$8.2 billion by 2031, growing at a CAGR of 7.0% from 2025 to 2031., according to DataM Intelligence.

United States: Recent Industry Developments
✅ In October 2025, Johnson & Johnson Vision expanded its U.S. femtosecond laser-assisted cataract surgery (FLACS) platform with the new CATALYS Precision Laser System update, partnering with major ophthalmic chains to improve refractive outcomes by 20% in premium IOL procedures.
✅ In September 2025, Alcon launched the next-generation CENTURION Vision System with active fluidics technology certified for enhanced anterior chamber stability, targeting high-volume ASCs via e-commerce platforms amid rising demand for safer phacoemulsification.
✅ In August 2025, Bausch + Lomb introduced the Stellaris Elite vision enhancement system compliant with FDA guidelines, distributed through eye care distributors for advanced vitrectomy and cataract combo procedures.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/cataract-surgery-devices-market?sindhuri

Japan: Recent Industry Developments
✅ In October 2025, NIDEK Co., Ltd. adopted AI-enhanced optical coherence tomography integration in its Japanese facilities, improving preoperative planning accuracy by 18% for export-grade phacoemulsification systems to Asia-Pacific markets.
✅ In September 2025, HOYA Surgical Optics collaborated with local hospitals to develop premium trifocal IOLs with enhanced intermediate vision, focusing on presbyopia correction under national aging population initiatives.
✅ In August 2025, Japan's Ministry of Health, Labour and Welfare subsidized femtosecond laser and advanced IOL R&D for 5,000 units of annual output, supporting high-precision cataract surgery in community clinics.

Asia-Pacific: Recent Industry Developments
✅ In October 2025, Aurolab opened a new intraocular lens manufacturing facility in India, supplying B2B clients in public hospitals with affordable hydrophobic acrylic IOLs for mass cataract programs.
✅ In September 2025, China's Aier Eye Hospital Group imported record volumes of phacoemulsification systems from the U.S., driven by rapid aging population and national blindness prevention campaigns.
✅ In August 2025, STAAR Surgical launched EVO Visian ICL in Southeast Asia, integrating with cataract refractive surgery for high-myopia correction in emerging vision care markets.

Market Trends & Drivers
The Global Cataract Surgery Devices Market is thriving due to surging demand for advanced intraocular lenses and phacoemulsification systems amid rising cataract prevalence (especially in aging populations), expanding applications in femtosecond laser-assisted surgery (FLACS), premium IOLs (multifocal, toric, EDOF), and minimally invasive techniques for better visual outcomes, and increasing awareness around early intervention and refractive cataract surgery. Key trends include innovation in technologies (e.g., active fluidics, AI-assisted planning, trifocal/EDOF IOLs), growth in outpatient and ambulatory surgery centers (ASCs), and increasing adoption in emerging markets (affordable monofocal IOLs, public health campaigns). The rise of medical tourism, premiumization in private eye care, and regulatory pushes for safety and efficacy (FDA 510(k), CE marking) are significantly accelerating market expansion amid shifting preferences for precise, patient-centered, and cost-effective cataract surgery solutions.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/cataract-surgery-devices-market?sindhuri

Competitive Landscape
The market is moderately consolidated among North American, European, and Asia-Pacific producers, with intense competition in premium IOL innovation, femtosecond laser integration, and cost-effective manufacturing.

» Alcon dominates globally with vertically integrated CENTURION phaco systems and Clareon IOLs for premium cataract surgery.
» Johnson & Johnson Vision leads in CATALYS FLACS and TECNIS multifocal IOLs for refractive outcomes.
» Bausch + Lomb excels in Stellaris Elite and enVista IOLs, focusing on advanced vitrectomy-cataract combo procedures.
» Carl Zeiss Meditec specializes in CALLISTO eye assistance and AT LISA tri IOLs for precision surgery.
» HOYA Surgical Optics drives Japanese growth with premium multifocal and toric IOLs.
» Aurolab targets APAC with affordable IOLs for public health cataract programs.
» STAAR Surgical focuses on EVO Visian ICL for refractive cataract correction.
» NIDEK Co., Ltd. innovates in diagnostic and surgical systems for ophthalmic workflows.
» Rayner Surgical Group strengthens presence with injectable IOLs for micro-incision surgery.
» Ophtec BV pioneers iris-fixated and toric IOLs for complex cases.

Buy now and enjoy a 30% year-end discount - limited-time offer!
https://www.datamintelligence.com/buy-now-page?report=cataract-surgery-devices-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Segmentation
☛ By Product Type
The cataract surgery devices market is segmented into Intraocular Lenses (IOLs), Phacoemulsification Systems, Femtosecond Lasers, Viscoelastic Devices, and Others. Intraocular Lenses (IOLs) dominate global consumption due to premium multifocal, toric, and EDOF demand. Meanwhile, Femtosecond Lasers are rapidly growing for precision capsulotomy and lens fragmentation.
☛ By Application
Applications of cataract surgery devices span Hospitals, Ophthalmic Clinics, and Ambulatory Surgery Centers. The Hospitals segment leads due to high-volume cataract surgeries and advanced equipment. Additionally, Ambulatory Surgery Centers are expanding with cost-effective outpatient procedures.
☛ By End-User
Based on end-user, the market is bifurcated into Public and Private. The Private segment dominates, driven by premium IOL adoption and faster access. The Public channel is also growing, with rising government-funded cataract programs in emerging markets.

Regional Analysis
» North America leads the global cataract surgery devices market, with the U.S. as the largest consumer driven by high cataract prevalence, advanced ophthalmic infrastructure, and strong adoption of premium IOLs and FLACS. Expansions in outpatient centers bolster regional dominance.
» Asia-Pacific exhibits robust growth as the fastest-expanding region, supported by massive cataract backlog in India and China, government initiatives, and affordable monofocal IOLs.
» Europe shows steady demand fueled by aging populations and private eye care. Countries such as Germany, France, and the UK prioritize multifocal and toric IOLs.
» The Middle East and Africa hold potential amid medical tourism and blindness prevention programs. Meanwhile, South America is emerging with imports for phacoemulsification systems.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription
✅ Competitive Landscape
✅ Technology Innovation Tracker
✅ Export vs. Domestic Consumption Analysis
✅ Ophthalmology Expert Insights
✅ Safety & Outcome Benchmarks
✅ Yield & Pricing Dynamics
✅ Live Retail & E-commerce Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.